Back to search

Article

Comparison of Prognosis Between Epidermal Growth Factor Mutation Positive and Negative Groups in Lung Adenocarcinoma Patients with Brain Metastases

2024-10-30

Abstract excerpt

<title>Abstract</title> <p>Introduction: Brain Metastasis (BM) in Non-Small Cell Lung Cancer (NSCLC) is still important reason of morbidity and mortality despite the advances in the cancer treatment. Using Tyrosine Kinase Inhibitors against Epidermal Growth Factor Receptors (EGFR) mutations revolutionized in NSCLC treatment. We investigated whether the presence of EGFR mutation influences survival in patients wi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
adbd3416-d086-5d88-bd02-d2c3cd9d43a1
DOI
10.21203/rs.3.rs-5316285/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of Prognosis Between Epidermal Growth Factor Mutation Positive and Negative Groups in Lung Adenocarcinoma Patients with Brain MetastasesDOI 10.21203/rs.3.rs-5316285/v1
The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status.Semantic proximity
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastasesSemantic proximity
Converging Survival Trends in Non-Small Cell Lung Cancer Patients With and Without Brain Metastasis Receiving State-of-the-Art TreatmentSemantic proximity
Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases.Semantic proximity
Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC.Semantic proximity
A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?Semantic proximity
Survival and prognostic factors in non-small cell lung cancer patients with brain metastases limited access to systemic therapySemantic proximity
Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients.Semantic proximity
Outcomes of 27 Non-Small Cell Lung Cancer Patients Receiving Resections of Paired Primary Pulmonary and Brain Metastatic Tumours: Is EGFR Negative Mutation of Brain Metastasis Bring More Benefit?Semantic proximity
In-depth exploration of the focus issues of TKI combined with radiotherapy for EGFR-mutant lung adenocarcinoma patients with brain metastasis: a systematic analysis based on literature metrology, meta-analysis, and real-world observational data.Semantic proximity
Identification of a High-Risk Group for Brain Metastases in Non-Small Cell Lung Cancer Patients.Semantic proximity
Risk Factors for Brain Metastases in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 43 StudiesSemantic proximity
Select a neighboring publication to make it the new centre.